FibroGen Appoints David DeLucia as Chief Financial Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. APLD
3. STZ
4. SPY
5. DVN
6. CRGY
7. ZETA
8. ARGX
9. RMR
10. TSM

Go back to FibroGen Appoints David DeLucia as Chief Financial Officer

H.C. Wainwright Starts FibroGen (FGEN) at Buy

December 17, 2024 7:57 AM EST

H.C. Wainwright analyst Matt Keller initiates coverage on FibroGen (NASDAQ: FGEN) with a Buy rating and a price target of $10.00.

The analyst comments "FibroGen's ADC pipeline could be a whole new ball game in mCRPC and beyond. We are initiating coverage of FibroGen with a Buy rating and $10 PT. FibroGens lead asset, FG-3246, is a novel antibody drug conjugate (ADC) targeting CD46 expressing tumors.... More